Animal viruses are parasites of animal cells that have characteristics such as heredity and replication. Viruses can be divided into non-enveloped and enveloped viruses if a lipid bilayer membrane surrounds them or not. All the membrane proteins of enveloped viruses that function in attachment to target cells or membrane fusion are modified by glycosylation. Glycosylation is one of the most common post-translational modifications of proteins and plays an important role in many biological behaviors, such as protein folding and stabilization, virus attachment to target cell receptors and inhibition of antibody neutralization. Glycans of the host receptors can also regulate the attachment of the viruses and then influence the virus entry. With the development of glycosylation research technology, the research and development of novel virus vaccines and antiviral drugs based on glycan have received increasing attention. Here, we review the effects of host glycans and viral proteins on biological behaviors of viruses, and the opportunities for prevention and treatment of viral infectious diseases.
Pancreatic cancer (PC) remains one of the top 10 causes of cancer-related death in recent years. Approximately 80% of PC patients are diagnosed at the middle or advanced stage and miss the opportunity for surgery. The demand for early diagnostic methods and reliable biomarkers is increasing, although a number of tumor markers such as CA19-9 and CEA have already been utilized in clinics. In this study, we analyzed the alteration of N-glycan of serum glycoproteins by mass spectrometry and lectin blotting. The results showed that bisecting GlcNAc structures of glycoproteins are significantly increased in PC patients’ sera. With Phaseolus vulgaris Erythroagglutinin (PHA-E) lectin that specifically recognizes bisecting GlcNAc N-glycans, the serum glycoproteins bearing bisecting GlcNAc in PC patients’ sera were pulled down and identified by nano-LC-MS/MS. Among them, ceruloplasmin (Cp) was screened out with a satisfied sensitivity and specificity in identifying PC from acute pancreatitis patients (AUC: 0.757) and normal healthy persons (AUC: 0.972), suggesting a close association between Cp and PC development and diagnosis. To prove that, the Cp expression in tumor tissues of PC patients was examined. The results showed that Cp was significantly upregulated in PC tissues compared to that in adjacent normal tissues. All these results suggested that PHA-E-positive Cp could be a potential PC-specific glycoprotein marker to distinguish PC patients from acute pancreatitis patients and normal persons.
α1-Acid glycoprotein (AGP) is a heavily glycosylated acute-phase protein whose N-linked glycan microheterogeneity plays an important regulatory role in pathophysiological processes. This review synthesizes decades of basic and clinical research, focusing on the five conserved N-glycosylation sites of AGP. Specifically, it summarizes disease-specific patterns of glycan remodeling in inflammation, cancer, and autoimmune diseases; discusses the molecular effects through which glycosylation modulates AGP conformation, receptor-binding properties, and downstream signaling pathways; examines disease-associated molecular fingerprints arising from site-specific glycosylation and their relationships with disease onset and progression; and highlights the translational potential of AGP glycosylation for early diagnosis, prognostic assessment, and targeted drug development. Current evidence indicates that most abnormalities in AGP glycosylation are associated with disease, whereas direct causal evidence for the involvement of glycosylation in disease progression remains incomplete. Important limitations also remain: the precise molecular mechanisms regulating AGP glycosylation under different pathological conditions have not been fully elucidated; experimental findings are inconsistent across cohorts and analytical platforms; and standardized analytical systems suitable for clinical application have yet to be established. By integrating the available evidence, this review provides a theoretical framework for advancing the translation of AGP glycosylation features into precision medicine.